Bisaro steers Impax to $6.4B Amneal merger, creating fifth-largest U.S. generics company

17th October 2017 Uncategorised 0

Surprise, surprise: Impax Labs, looking to bulk up amid generics pricing pressure and newly helmed by M&A specialist Paul Bisaro, has struck a deal.

More: Bisaro steers Impax to .4B Amneal merger, creating fifth-largest U.S. generics company
Source: fierce